Storey RF - Search Results

1

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.

Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, Wickens M, Emanuelsson H, Gurbel P, Grande P, Cannon CP. Storey RF, et al. J Am Coll Cardiol. 2007 Nov 6;50(19):1852-6. doi: 10.1016/j.jacc.2007.07.058. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980251 Free article. Clinical Trial.

2

Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists.

Storey RF, Wilcox RG, Heptinstall S. Storey RF, et al. Circulation. 1998 Oct 20;98(16):1616-21. doi: 10.1161/01.cir.98.16.1616. Circulation. 1998. PMID: 9778326 Clinical Trial.

3

A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies.

Storey RF, May JA, Wilcox RG, Heptinstall S. Storey RF, et al. Thromb Haemost. 1999 Oct;82(4):1307-11. Thromb Haemost. 1999. PMID: 10544919

4

Laboratory investigation of platelet function.

Storey RF, Heptinstall S. Storey RF, et al. Clin Lab Haematol. 1999 Oct;21(5):317-29. doi: 10.1046/j.1365-2257.1999.00254.x. Clin Lab Haematol. 1999. PMID: 10646074 Review.

5

The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.

Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. Storey RF, et al. Br J Haematol. 2000 Sep;110(4):925-34. doi: 10.1046/j.1365-2141.2000.02208.x. Br J Haematol. 2000. PMID: 11054084 Free article.

6

Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.

Storey RF, Oldroyd KG, Wilcox RG. Storey RF, et al. Thromb Haemost. 2001 Mar;85(3):401-7. Thromb Haemost. 2001. PMID: 11307804 Clinical Trial.

7

The P2Y12 receptor as a therapeutic target in cardiovascular disease.

Storey RF. Storey RF. Platelets. 2001 Jun;12(4):197-209. doi: 10.1080/09537100120058739. Platelets. 2001. PMID: 11454254 Review.

8

Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.

Storey RF, Newby LJ, Heptinstall S. Storey RF, et al. Platelets. 2001 Nov;12(7):443-7. doi: 10.1080/09537100120085450. Platelets. 2001. PMID: 11674863

9

Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.

Storey RF, Judge HM, Wilcox RG, Heptinstall S. Storey RF, et al. Thromb Haemost. 2002 Sep;88(3):488-94. Thromb Haemost. 2002. PMID: 12353080

10

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.

Storey RF, Wilcox RG, Heptinstall S. Storey RF, et al. Platelets. 2002 Nov;13(7):407-13. doi: 10.1080/0953710021000024402. Platelets. 2002. PMID: 12487788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page